Acide alendronique And NotPierre D. Delmas

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000346	Roger M. Zebaze [Australie] ; Cesar Libanati [États-Unis] ; Matthew Austin [États-Unis] ; Ali Ghasem-Zadeh [Australie] ; David A. Hanley [Canada] ; Jose R. Zanchetta [Argentine] ; Thierry Thomas [France] ; Stephanie Boutroy [France] ; Cesar E. Bogado [Argentine] ; John P. Bilezikian [États-Unis] ; Ego Seeman [Australie]	Differing effects of denosumab and alendronate on cortical and trabecular bone
000361	C. Roux [France] ; L. C. Hofbauer [Allemagne] ; P. R. Ho [États-Unis] ; J. D. Wark [Australie] ; M. C. Zillikens [Pays-Bas] ; A. Fahrleitner-Pammer [Autriche] ; F. Hawkins [Espagne] ; M. Micaelo [Portugal] ; S. Minisola [Italie] ; N. Papaioannou [Grèce] ; M. Stone [Royaume-Uni] ; I. Ferreira [États-Unis] ; S. Siddhanti [États-Unis] ; R. B. Wagman [États-Unis] ; J. P. Brown [Canada]	Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
003465	D. M. Reid [Royaume-Uni] ; D. Hosking [Royaume-Uni] ; D. Kendler [Canada] ; M. L. Brandi [Italie] ; J. D. Wark [Australie] ; J. F. Marques-Neto [Brésil] ; G. Weryha [France] ; N. Verbruggen [États-Unis] ; C. M. Hustad [États-Unis] ; E. M. Mahlis [États-Unis] ; M. E. Melton [États-Unis]	A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis : 24-month results from FACTS-International
005048	B. L. Gulson [Australie] ; K. J. Mizon [Australie] ; H. Smith [Australie] ; J. Eisman [Australie] ; J. M. Palme [Australie] ; M. J. Korsch [Australie] ; J. Donnelly [Australie] ; K. Waite [Australie]	Bone turnover in elderly females and males using bisphosphonate treatment: A pilot study

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024